BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33926484)

  • 21. Antileukemic Activity of 2-Deoxy-d-Glucose through Inhibition of N-Linked Glycosylation in Acute Myeloid Leukemia with FLT3-ITD or c-KIT Mutations.
    Larrue C; Saland E; Vergez F; Serhan N; Delabesse E; Mansat-De Mas V; Hospital MA; Tamburini J; Manenti S; Sarry JE; Récher C
    Mol Cancer Ther; 2015 Oct; 14(10):2364-73. PubMed ID: 26206337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Venetoclax Synergistically Enhances the Anti-leukemic Activity of Vosaroxin Against Acute Myeloid Leukemia Cells Ex Vivo.
    Liu F; Knight T; Su Y; Edwards H; Wang G; Wang Y; Taub JW; Lin H; Sun L; Ge Y
    Target Oncol; 2019 Jun; 14(3):351-364. PubMed ID: 31115744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CPT1B, a metabolic molecule, is also an independent risk factor in CN-AML.
    Ling Q; Mao S; Pan J; Wei W; Qian Y; Li F; Huang S; Ye W; Lin X; Huang J; Wang J; Jin J
    Cancer Biomark; 2023; 37(3):133-145. PubMed ID: 36938722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of a G-quadruplex-stabilizing small molecule that synergizes with Navitoclax to induce cytotoxicity in acute myeloid leukemia cells.
    Montoya JJ; Turnidge MA; Wai DH; Patel AR; Lee DW; Gokhale V; Hurley LH; Arceci RJ; Wetmore C; Azorsa DO
    BMC Cancer; 2019 Dec; 19(1):1251. PubMed ID: 31881855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Restoration of CPT1A-mediated fatty acid oxidation in mesothelial cells protects against peritoneal fibrosis.
    Su W; Hu Z; Zhong X; Cong A; Zhang Y; Zhou Z; Li J; Su C; Huang Y; Cao W
    Theranostics; 2023; 13(13):4482-4496. PubMed ID: 37649600
    [No Abstract]   [Full Text] [Related]  

  • 26. Targeting Cellular Metabolism in Acute Myeloid Leukemia and The Role of Patient Heterogeneity.
    Grønningsæter IS; Reikvam H; Aasebø E; Bartaula-Brevik S; Tvedt TH; Bruserud Ø; Hatfield KJ
    Cells; 2020 May; 9(5):. PubMed ID: 32392896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of CHK1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells.
    Zhao J; Niu X; Li X; Edwards H; Wang G; Wang Y; Taub JW; Lin H; Ge Y
    Oncotarget; 2016 Jun; 7(23):34785-99. PubMed ID: 27166183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Side-by-side comparison of BH3-mimetics identifies MCL-1 as a key therapeutic target in AML.
    Ewald L; Dittmann J; Vogler M; Fulda S
    Cell Death Dis; 2019 Dec; 10(12):917. PubMed ID: 31801941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms responsible for the synergistic antileukemic interactions between ATR inhibition and cytarabine in acute myeloid leukemia cells.
    Ma J; Li X; Su Y; Zhao J; Luedtke DA; Epshteyn V; Edwards H; Wang G; Wang Z; Chu R; Taub JW; Lin H; Wang Y; Ge Y
    Sci Rep; 2017 Feb; 7():41950. PubMed ID: 28176818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long non-coding RNA taurine-upregulated gene 1 correlates with poor prognosis, induces cell proliferation, and represses cell apoptosis via targeting aurora kinase A in adult acute myeloid leukemia.
    Wang X; Zhang L; Zhao F; Xu R; Jiang J; Zhang C; Liu H; Huang H
    Ann Hematol; 2018 Aug; 97(8):1375-1389. PubMed ID: 29654398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downregulation of GLUT3 Promotes Apoptosis and Chemosensitivity of Acute Myeloid Leukemia Cells via EGFR Signaling.
    Zhuang Y; Zhao J; Xu X; Bi L
    Arch Iran Med; 2018 Feb; 21(2):73-78. PubMed ID: 29664658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of Mcl-1 with the pan-Bcl-2 family inhibitor (-)BI97D6 overcomes ABT-737 resistance in acute myeloid leukemia.
    Pan R; Ruvolo VR; Wei J; Konopleva M; Reed JC; Pellecchia M; Andreeff M; Ruvolo PP
    Blood; 2015 Jul; 126(3):363-72. PubMed ID: 26045609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cotargeting BCL-2 and PI3K Induces BAX-Dependent Mitochondrial Apoptosis in AML Cells.
    Rahmani M; Nkwocha J; Hawkins E; Pei X; Parker RE; Kmieciak M; Leverson JD; Sampath D; Ferreira-Gonzalez A; Grant S
    Cancer Res; 2018 Jun; 78(11):3075-3086. PubMed ID: 29559471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NQO1/CPT1A promotes the progression of pancreatic adenocarcinoma via fatty acid oxidation.
    Xu R; Liu Y; Ma L; Sun Y; Liu H; Yang Y; Jin T; Yang D
    Acta Biochim Biophys Sin (Shanghai); 2023 May; 55(5):758-768. PubMed ID: 37249337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pan-Bcl2 Inhibitor AT101 Activates the Intrinsic Apoptotic Pathway and Causes DNA Damage in Acute Myeloid Leukemia Stem-Like Cells.
    Zhang L; Zhou Y; Chen K; Shi P; Li Y; Deng M; Jiang Z; Wang X; Li P; Xu B
    Target Oncol; 2017 Oct; 12(5):677-687. PubMed ID: 28710745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exosomal CD44 Transmits Lymph Node Metastatic Capacity Between Gastric Cancer Cells
    Wang M; Yu W; Cao X; Gu H; Huang J; Wu C; Wang L; Sha X; Shen B; Wang T; Yao Y; Zhu W; Huang F
    Front Oncol; 2022; 12():860175. PubMed ID: 35359362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The CXCR4 inhibitor BL-8040 induces the apoptosis of AML blasts by downregulating ERK, BCL-2, MCL-1 and cyclin-D1 via altered miR-15a/16-1 expression.
    Abraham M; Klein S; Bulvik B; Wald H; Weiss ID; Olam D; Weiss L; Beider K; Eizenberg O; Wald O; Galun E; Avigdor A; Benjamini O; Nagler A; Pereg Y; Tavor S; Peled A
    Leukemia; 2017 Nov; 31(11):2336-2346. PubMed ID: 28280274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein kinase CK2alpha as an unfavorable prognostic marker and novel therapeutic target in acute myeloid leukemia.
    Kim JS; Eom JI; Cheong JW; Choi AJ; Lee JK; Yang WI; Min YH
    Clin Cancer Res; 2007 Feb; 13(3):1019-28. PubMed ID: 17289898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting PI3K, mTOR, ERK, and Bcl-2 signaling network shows superior antileukemic activity against AML ex vivo.
    Su Y; Li X; Ma J; Zhao J; Liu S; Wang G; Edwards H; Taub JW; Lin H; Ge Y
    Biochem Pharmacol; 2018 Feb; 148():13-26. PubMed ID: 29208365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA 34b inhibits cell proliferation in pediatric acute myeloid leukemia via regulating LDHA.
    Qi HX; Cao Q; Zhou GP; Sun XZ; Zhou WD; Hong Z; Hu J; Juan CX; Li S; Kuai WX
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5351-5359. PubMed ID: 31298387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.